Skip to content
Home/Companies/Healthcare/Timberlyne Therapeutics
TT

Timberlyne Therapeutics

Healthcare·US·Active·1yr hold

Timberlyne Therapeutics is a healthcare company, headquartered in US.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Timberlyne Therapeutics?

Timberlyne Therapeutics is currently owned by Abingworth through Abingworth Bioventures 8 (2021 vintage), since 2025.

Hand-verified · updated 2026-06-10

Abingworth
Investor
Abingworth
Abingworth Bioventures 8 · 2021 · Life Sciences VC

Key facts

HQUS
SectorHealthcare
StatusActive

More from Abingworth Bioventures 8

Other portfolio companies in the same fund.

Cytospire Therapeutics
Active
BiotechUK· 2026
AdvanCell
Active
BiotechAustralia· 2025
Antares Therapeutics
Active
BiotechUS· 2025
Solve Therapeutics
Active
BiotechUS· 2025
Myricx Bio
Active
BiotechUK· 2024
Ascend Gene & Cell Therapies
Active
BiotechUK· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings